Search research articles
Contact Us
Filters
Showing results (111-120 of 168) with videos related to
Page
of 17
Sort By:
Paediatric Drugs
|
November 6, 2024
Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine
Riccardo Masetti, Gianluca Bossù, Edoardo Muratore, et al.
Antibiotics (Basel, Switzerland)
|
October 27, 2022
Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant <i>Staphylococcus aureus</i>: A Retrospective Single-Centre Experience
Maria Mazzitelli, Milo Gatti, Vincenzo Scaglione, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
July 29, 2023
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?
Milo Gatti, Matteo Rinaldi, Luciano Potena, et al.
International Journal of Cancer
|
April 12, 2021
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis
Daria Maria Filippini, Milo Gatti, Vito Di Martino, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2025
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?
Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Antimicrobial Agents and Chemotherapy
|
October 29, 2025
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?
Manjunath P Pai, Pier Giorgio Cojutti, Milo Gatti, et al.
International Journal of Antimicrobial Agents
|
March 6, 2023
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections
Milo Gatti, Pierluigi Viale, Pier Giorgio Cojutti, et al.
Antimicrobial Agents and Chemotherapy
|
September 22, 2025
Targeting <i>Pseudomonas aeruginosa</i> resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion
Pier Giorgio Cojutti, Manjunath P Pai, Milo Gatti, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 22, 2022
The impact of preservation fluid culture on graft site arteritis: A systematic review and meta-analysis
Matteo Rinaldi, Cecilia Bonazzetti, Milo Gatti, et al.
International Journal of Antimicrobial Agents
|
October 14, 2023
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study)
Matteo Rinaldi, Michele Bartoletti, Cecilia Bonazzetti, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 168) with videos related to
Sort By:
Page
of 17
Paediatric Drugs
|
November 6, 2024
Therapeutic Drug Monitoring of Antimicrobial Drugs in Children with Cancer: A New Tool for Personalized Medicine
Riccardo Masetti, Gianluca Bossù, Edoardo Muratore, et al.
Antibiotics (Basel, Switzerland)
|
October 27, 2022
Off-Label Use of Dalbavancin for Sequential Treatment of Spondylodiscitis by Methicillin-Resistant <i>Staphylococcus aureus</i>: A Retrospective Single-Centre Experience
Maria Mazzitelli, Milo Gatti, Vincenzo Scaglione, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
July 29, 2023
Does therapeutic drug monitoring (TDM) of trough concentrations suffice for optimizing preemptive therapy with ganciclovir of cytomegalovirus infections in non-renal solid organ transplant recipients?
Milo Gatti, Matteo Rinaldi, Luciano Potena, et al.
International Journal of Cancer
|
April 12, 2021
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis
Daria Maria Filippini, Milo Gatti, Vito Di Martino, et al.
The Journal of Antimicrobial Chemotherapy
|
March 24, 2025
A pre-post quasi-experimental study of the impact of TDM-guided aggressive pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftolozane/tazobactam monotherapy in treating severe Pseudomonas aeruginosa infections: a strategy useful for raising the bar?
Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Antimicrobial Agents and Chemotherapy
|
October 29, 2025
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?
Manjunath P Pai, Pier Giorgio Cojutti, Milo Gatti, et al.
International Journal of Antimicrobial Agents
|
March 6, 2023
A descriptive case series of the relationship between maintenance of conservative PK/PD efficacy thresholds of dalbavancin over time and clinical outcome in long-term treatment of staphylococcal osteoarticular infections
Milo Gatti, Pierluigi Viale, Pier Giorgio Cojutti, et al.
Antimicrobial Agents and Chemotherapy
|
September 22, 2025
Targeting <i>Pseudomonas aeruginosa</i> resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion
Pier Giorgio Cojutti, Manjunath P Pai, Milo Gatti, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
October 22, 2022
The impact of preservation fluid culture on graft site arteritis: A systematic review and meta-analysis
Matteo Rinaldi, Cecilia Bonazzetti, Milo Gatti, et al.
International Journal of Antimicrobial Agents
|
October 14, 2023
Tolerability of pulsed high-dose L-AmB as pre-emptive therapy in patients at high risk for intra-abdominal candidiasis: A phase 2 study (LAMBDA study)
Matteo Rinaldi, Michele Bartoletti, Cecilia Bonazzetti, et al.
Page
of 17